Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Mar-24 5:46 PM View:  | O'Connor Daniel President and CEO Director | Ambrx Biopharma, Inc. (AMAM) | 07-Mar-24 | Disposition | 48,202 | -- | -- | (100%) 48.2K to 0 | |
| 07-Mar-24 5:41 PM View: | Nelson Sonja Chief Financial Officer | Ambrx Biopharma, Inc. (AMAM) | 07-Mar-24 | Disposition | 22,936 | -- | -- | (100%) 22.94K to 0 | |
| 11-Dec-23 5:17 PM View: | Nelson Sonja Chief Financial Officer | Ambrx Biopharma, Inc. (AMAM) | 11-Dec-23 | Grant | 50,000 | -- | -- | 10% 495.78K to 545.78K | |
| 11-Dec-23 5:19 PM View: | Aromando Andrew Chief Operating Officer | Ambrx Biopharma, Inc. (AMAM) | 11-Dec-23 | Grant | 100,000 | -- | -- | 1080% 9.26K to 109.26K | |
| 11-Dec-23 5:15 PM View: | O'Connor Daniel President and CEO Director | Ambrx Biopharma, Inc. (AMAM) | 11-Dec-23 | Grant | 750,000 | -- | -- | 122% 613.33K to 1.36M | |
| 31-Oct-23 5:00 PM View: | O'Connor Daniel President and CEO Director | Ambrx Biopharma, Inc. (AMAM) | 27-Oct-23 | Market Sale (Planned) | 50,012 | $9.82 | $491,118.00 | (13%) 392.86K to 342.85K | (< 1%) |
| 31-Oct-23 5:00 PM View: | Nelson Sonja Chief Financial Officer | Ambrx Biopharma, Inc. (AMAM) | 27-Oct-23 | Market Sale (Planned) | 12,778 | $9.82 | $125,480.00 | (9%) 142.86K to 130.08K | (< 1%) |
| 25-Oct-23 4:15 PM View: | Cormorant Asset Management,... 10% Owner | Ambrx Biopharma, Inc. (AMAM) | 23-Oct-23 | Purchase | 1,307,310 | $6.99 | $9,139,540.00 | 13% 9.92M to 11.23M |
